Related references
Note: Only part of the references are listed.Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
Paulina Aleksandrowicz et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Present and future arboviral threats
Scott C. Weaver et al.
ANTIVIRAL RESEARCH (2010)
Entry of Bunyaviruses into Mammalian Cells
Pierre-Yves Lozach et al.
CELL HOST & MICROBE (2010)
Arboviral Encephalitides: Transmission, Emergence, and Pathogenesis
Bradley S. Hollidge et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Roles of AP-2 in Clathrin-Mediated Endocytosis
Emmanuel Boucrot et al.
PLOS ONE (2010)
La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic
Samantha S. Soldan et al.
VIROLOGY (2010)
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
Mohammad F. Saeed et al.
PLOS PATHOGENS (2010)
Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent
Melinda Simon et al.
JOURNAL OF GENERAL VIROLOGY (2009)
The Incidence Risk, Clustering, and Clinical Presentation of La Crosse Virus Infections in the Eastern United States, 2003-2007
Andrew D. Haddow et al.
PLOS ONE (2009)
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
Philip Meuleman et al.
HEPATOLOGY (2008)
Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrinmediated endocytosis
Eliana G. Acosta et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults
Jeffrey M. Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Global trends in emerging infectious diseases
Kate E. Jones et al.
NATURE (2008)
Oropouche virus entry into HeLa cells involves clathrin and requires endosomal acidification
Rodrigo I. M. Santos et al.
VIRUS RESEARCH (2008)
Pathways of clathrin-independent endocytosis
Satyajit Mayor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide
Matthew L. Plassmeyer et al.
VIROLOGY (2007)
Dynasore puts a new spin on dynamin: a surprising dual role during vesicle formation
Sharif R. Nankoe et al.
TRENDS IN CELL BIOLOGY (2006)
Dynasore, a cell-permeable inhibitor of dynamin
Eric Macia et al.
DEVELOPMENTAL CELL (2006)
Rab proteins, connecting transport and vesicle fusion
I Jordens et al.
TRAFFIC (2005)
Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers
M Kirkham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
California serogroup, GC (Gl) glycoprotein is the principal determinant of pH-dependent cell fusion and entry
ML Plassmeyer et al.
VIROLOGY (2005)
Nucleic acid amplification assays for detection of La Crosse virus RNA
AJ Lambert et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway
JJH Chu et al.
JOURNAL OF VIROLOGY (2004)
Assembly of endocytic machinery around individual influenza viruses during viral entry
MJ Rust et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine
M Nawa et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Vaccines and animal models for arboviral encephalitides
A Nalca et al.
ANTIVIRAL RESEARCH (2003)
La Crosse virus: replication in vertebrate and invertebrate hosts
MK Borucki et al.
MICROBES AND INFECTION (2002)
Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis
M Jin et al.
VIROLOGY (2002)
Rapid cycling of lipid raft markers between the cell surface and Golgi complex
BJ Nichols et al.
JOURNAL OF CELL BIOLOGY (2001)
La crosse encephalitis in children.
JE McJunkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Rab proteins as membrane organizers
M Zerial et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140
A Trkola et al.
JOURNAL OF VIROLOGY (2001)
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
JM Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
